Detection of dual TEL-ABL transcripts and a Tel-Abl protein containing phosphotyrosine in a chronic myeloid leukemia patient.
Lin
H
H
Guo
J Q
JQ
Andreeff
M
M
Arlinghaus
R B
RB
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001483:Base Sequence; D001549:Benzamides; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005091:Exons / Q000235:genetics; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D000068877:Imatinib Mesylate; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000097:blood / Q000188:drug therapy / Q000235:genetics* / Q000601:surgery; D007962:Leukocytes / Q000737:chemistry*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D014411:Neoplastic Stem Cells / Q000737:chemistry*; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors / Q000235:genetics*; D010879:Piperazines / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases; D011743:Pyrimidines / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis / Q000097:blood*; D012334:RNA, Neoplasm / Q000032:analysis / Q000097:blood*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013154:Spleen / Q000737:chemistry / Q000473:pathology; D013156:Splenectomy; D014407:Tumor Cells, Cultured / Q000187:drug effects; D000097764:ETS Translocation Variant 6 Protein
D001549:Benzamides; D004791:Enzyme Inhibitors; D006918:Hydroxyurea; D000068877:Imatinib Mesylate; D007155:Immunologic Factors; D016898:Interferon-alpha; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011505:Protein-Tyrosine Kinases; D011743:Pyrimidines; D012333:RNA, Messenger; D012334:RNA, Neoplasm; C426234:TEL-ABL fusion protein, human; D000097764:ETS Translocation Variant 6 Protein